| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazak. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal. Cureus. vol 15. issue 10. 2023-12-01. PMID:38022067. |
neuroleptic malignant syndrome (nms) is a potentially fatal side effect that occurs in patients taking antipsychotics. |
2023-12-01 |
2023-12-07 |
Not clear |
| Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, Wataru Wakabayashi, Keita Oura, Satoshi Nakao, Nanaka Ichihara, Yuka Nokura, Moe Yamashita, Kensuke Matsui, Hideyuki Tanaka, Mayuko Masuta, Ichiro Ieiri, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system. Heliyon. vol 9. issue 11. 2023-11-30. PMID:38034668. |
adverse events (aes) of antipsychotic drugs include neuroleptic malignant syndrome (nms), which presents complex clinical symptoms, resulting in a fatal outcome. |
2023-11-30 |
2023-12-10 |
Not clear |
| Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazak. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal. Cureus. vol 15. issue 10. 2023-12-01. PMID:38022067. |
neuroleptic malignant syndrome (nms) is a potentially fatal side effect that occurs in patients taking antipsychotics. |
2023-11-29 |
2023-12-07 |
Not clear |
| Ahmet Turan Isik, Derya Kaya, Mehmet Selman Ontan, Feyza Mutlay, Esra Ates Bulut, Fatma Sena Dost, Neziha Erken, Ali Ekrem Aydi. Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic. Clinical neuropharmacology. vol 46. issue 6. 2023-11-14. PMID:37962307. |
neuroleptic malignant syndrome (nms) is a life-threatening condition that occurs as an adverse reaction to antipsychotic and antiemetic agents or sudden withdrawal of dopaminergic medications. |
2023-11-14 |
2023-11-20 |
Not clear |
| Yoji Kyotani, Jing Zhao, Kiichi Nakahira, Masanori Yoshizum. The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome. Scientific reports. vol 13. issue 1. 2023-10-30. PMID:37891209. |
neuroleptic malignant syndrome (nms) is a rare but serious and sometimes fatal complication in patients taking antipsychotic drugs, and its underlying mechanism still remains unclear. |
2023-10-30 |
2023-11-08 |
Not clear |
| Autumn R Schultz, Sarina Singh, Carolyn E Linek-Rajapaksha, Heather R Goode, Adam J Fusic. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use. Clinical neuropharmacology. 2023-10-24. PMID:37874611. |
neuroleptic malignant syndrome (nms) is a rare life-threatening condition that providers should be cognizant of when prescribing dopamine-receptor antagonists. |
2023-10-24 |
2023-11-08 |
Not clear |
| Ahmet Turan Isik, Derya Kaya, Mehmet Selman Ontan, Feyza Mutlay, Esra Ates Bulut, Fatma Sena Dost, Neziha Erken, Ali Ekrem Aydi. Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic. Clinical neuropharmacology. 2023-09-25. PMID:37747824. |
neuroleptic malignant syndrome (nms) is a life-threatening condition that occurs as an adverse reaction to antipsychotic and antiemetic agents or sudden withdrawal of dopaminergic medications. |
2023-09-25 |
2023-10-07 |
Not clear |
| Adela G Buciuc, Paula Traugott, Carlos R Dange. An Unusual Presentation of Serotonin Syndrome and Subsequent Catatonia in a Patient With a Family History of Huntington's Disease. Cureus. vol 15. issue 9. 2023-09-18. PMID:37720123. |
neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) represent serious life-threatening conditions that share phenotypic and pathophysiologic features due to intricate interactions between the dopaminergic and serotoninergic systems. |
2023-09-18 |
2023-10-07 |
Not clear |
| Ahmed Ali Aziz, Muhammad Ali Aziz, Rehan Sha. A Rare Case of Malignant Syndrome in Parkinson's Disease Caused by Severe Dehydration and Complicated by Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). Cureus. vol 15. issue 7. 2023-08-25. PMID:37621801. |
the syndrome is quite similar to neuroleptic malignant syndrome (nms) in presentation and is a potentially fatal syndrome. |
2023-08-25 |
2023-09-07 |
Not clear |
| Jordan Virolle, Maximilien Redon, François Montastruc, Simon Taïb, Alexis Revet, Vuk Zivkovic, Julien Da Costa, Etienne Ver. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review. Schizophrenia research. 2023-08-20. PMID:37599139. |
antipsychotic-induced catatonia (aic) and neuroleptic malignant syndrome (nms) are life-threatening adverse reactions to antipsychotic medication. |
2023-08-20 |
2023-09-07 |
Not clear |
| Mian Zarshawn H Jan, Patricia Figgs, Gerard Gallucci, Romona Bacchu. COVID-19 Pandemic-Delayed Diagnosis and Treatment of Atypical Neuroleptic Malignant Syndrome in a Violent Forensics Patient With Intellectual Disability and Treatment-Resistant Schizophrenia. Cureus. vol 15. issue 7. 2023-08-15. PMID:37581140. |
this case report highlights an episode of neuroleptic malignant syndrome (nms) in a forensic psychiatry inpatient unit and how the coronavirus disease (covid) pandemic, as well as, an atypical presentation of nms delayed diagnosis and treatment of a patient, which could have been fatal. |
2023-08-15 |
2023-09-07 |
Not clear |
| Leila R Poian, Silvana Chiavegatt. Serotonin Syndrome: The Role of Pharmacology in Understanding Its Occurrence. Cureus. vol 15. issue 5. 2023-06-13. PMID:37309350. |
furthermore, ss and neuroleptic malignant syndrome (nms) seem to be part of the same pathological spectrum, especially in atypical nms cases. |
2023-06-13 |
2023-08-14 |
Not clear |
| Koichi Nisijim. Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden. International medical case reports journal. vol 16. 2023-05-18. PMID:37200957. |
anticholinergic drugs, such as biperiden, benztropine, and diphenhydramine, were used for neuroleptic malignant syndrome (nms) in the 1980s and 1990s. |
2023-05-18 |
2023-08-14 |
Not clear |
| Sanchit Duhan, Bijeta Keisham, Anubhav Jai. An Unusual Cause of Persistent Tachycardia: Atypical Neuroleptic Malignant Syndrome. Cureus. vol 15. issue 3. 2023-04-24. PMID:37090340. |
neuroleptic malignant syndrome (nms) is a rare, life-threatening emergency caused more commonly by typical antipsychotics. |
2023-04-24 |
2023-08-14 |
Not clear |
| Muhammad U Rohail, Ayub Khan, Rhani M Pflaum, Mitul Patel, Melissa A Mood. An Atypical Case of Neuroleptic Malignant Syndrome Associated With Ciprofloxacin and Quetiapine. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065407. |
given the patient's autonomic instability, altered mental status, muscle rigidity, and leukocytosis, psychiatric consultation revealed an atypical case of neuroleptic malignant syndrome (nms). |
2023-04-17 |
2023-08-14 |
Not clear |
| Lauren Katzell, Emily Beydler, Amílcar Silva Dos Santos, Richa Vijayvargiya, Brent R Car. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report. Frontiers in psychiatry. vol 14. 2023-04-10. PMID:37032940. |
neuroleptic malignant syndrome (nms), thought to arise through dopamine antagonism, is life-threatening. |
2023-04-10 |
2023-08-14 |
Not clear |
| Cameron G Hanson, Amit Chopr. A Case of Neuroleptic Malignant Syndrome Presenting as Anxiety. Cureus. vol 15. issue 3. 2023-04-10. PMID:37033557. |
neuroleptic malignant syndrome (nms) is a rare but potentially lethal complication of dopamine antagonist use. |
2023-04-10 |
2023-08-14 |
Not clear |
| Johana Patricia Mogollon Díaz, Linda Yurani Lizcano Toloza, Angie Yarlady Serrano García, Camilo Andrés Alquichire Luna, Diego Fernando García Bohorquez, María Fernanda Chaparro Durán, María Valentina Cáceres Valer. Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report. Revista Colombiana de psiquiatria (English ed.). 2023-04-08. PMID:37031016. |
neuroleptic malignant syndrome (nms) is uncommon, with an incidence of 0.01%-3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death. |
2023-04-08 |
2023-08-14 |
Not clear |
| Brianna Cocuzzo, Kristy A Fisher, Clara L Alvarez Villalb. Neuroleptic Malignant Syndrome Status Post Anoxic Brain Injury: A Case Presentation of Heightened Susceptibility in the Brain Injury Population. Cureus. vol 15. issue 3. 2023-04-07. PMID:37025743. |
neuroleptic malignant syndrome (nms), a potentially life-threatening neurological emergency characterized by muscle rigidity, altered mental status (ams), autonomic instability, and hyperthermia, is most commonly precipitated by high-potency first-generation antipsychotics due to central dopamine receptor blockade. |
2023-04-07 |
2023-08-14 |
Not clear |
| Maxwell Miller, Alisa Zezetko, Ritvij Satodiy. Development of Atypical Neuroleptic Malignant Syndrome After Treatment of Cocaine Intoxication: A Case Report and Literature Review. Cureus. vol 15. issue 2. 2023-04-03. PMID:37007397. |
neuroleptic malignant syndrome (nms) is a life-threatening condition classically associated with the use of antipsychotic medications. |
2023-04-03 |
2023-08-14 |
Not clear |